Highlights
- Market Cap
- $2.32B
- Enterprise Value
- $4.72B
- EPS (TTM)
- -$2.99
- Total Revenue (TTM)
- $3.68B
- Gross Profit (TTM)
- $1.84B
- EBITDA (TTM)
- $7.00M
- Year Range
- $9.85 - $17.18
- Target Price
- $13.33
- ROA (TTM)
- -11.00%
- ROE (TTM)
- -44.55%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in DENTSPLY SIRONA Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
DENTSPLY SIRONA Inc. (XRAY) has returned 1.49% so far this year and -19.39% over the past 12 months. Over the last ten years, XRAY has returned -14.13% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.
DENTSPLY SIRONA Inc.
- 1D
- 3.57%
- 1M
- -20.98%
- YTD
- 1.49%
- 6M
- -7.27%
- 1Y
- -19.39%
- 3Y*
- -31.49%
- 5Y*
- -27.25%
- 10Y*
- -14.13%
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Apr 25, 1991, XRAY's average daily return is +0.05%, while the average monthly return is +0.87%. At this rate, your investment would double in approximately 6.7 years.
Historically, 58% of months were positive and 42% were negative. The best month was Sep 1992 with a return of +37.6%, while the worst month was Jun 1998 at -25.8%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 5 months.
On a daily basis, XRAY closed higher 49% of trading days. The best single day was Mar 1, 2019 with a return of +17.7%, while the worst single day was Nov 7, 2024 at -28.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 9.10% | 17.72% | -20.98% | 1.49% | |||||||||
| 2025 | 4.11% | -16.24% | -8.80% | -6.96% | 14.96% | 0.38% | -9.89% | -0.07% | -10.10% | -0.63% | -10.07% | 2.25% | -36.84% |
| 2024 | -2.36% | -5.96% | 2.06% | -9.58% | -6.66% | -10.50% | 8.95% | -6.82% | 7.65% | -14.38% | -15.19% | -2.60% | -45.28% |
| 2023 | 15.67% | 3.37% | 3.56% | 6.75% | -13.86% | 11.19% | 3.75% | -10.67% | -7.52% | -10.98% | 4.41% | 12.54% | 13.50% |
| 2022 | -4.25% | 1.35% | -8.86% | -18.75% | -1.08% | -9.36% | 1.20% | -9.37% | -13.12% | 8.71% | -1.82% | 5.65% | -42.11% |
| 2021 | 2.16% | -0.79% | 20.44% | 5.80% | -0.87% | -5.31% | 4.39% | -6.57% | -5.74% | -1.45% | -14.81% | 14.69% | 7.32% |
Benchmark Metrics
DENTSPLY SIRONA Inc. has an annualized alpha of 4.36%, beta of 0.73, and R² of 0.19 versus S&P 500 Index. Calculated based on daily prices since April 26, 1991.
- This stock participated in 79.84% of S&P 500 Index downside but only 74.81% of its upside — more exposed to losses than it benefited from rallies.
- R² of 0.19 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 4.36%
- Beta
- 0.73
- R²
- 0.19
- Upside Capture
- 74.81%
- Downside Capture
- 79.84%
Return for Risk
Risk / Return Rank
XRAY ranks 24 for risk / return — below 24% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for DENTSPLY SIRONA Inc. (XRAY) and compare them to a chosen benchmark (S&P 500 Index).
| XRAY | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.40 | 0.90 | -1.29 |
Sortino ratioReturn per unit of downside risk | -0.30 | 1.39 | -1.69 |
Omega ratioGain probability vs. loss probability | 0.96 | 1.21 | -0.25 |
Calmar ratioReturn relative to maximum drawdown | -0.48 | 1.40 | -1.88 |
Martin ratioReturn relative to average drawdown | -0.91 | 6.61 | -7.52 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore XRAY risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
DENTSPLY SIRONA Inc. provided a 4.14% dividend yield over the last twelve months, with an annual payout of $0.48 per share. The company has been increasing its dividends for 27 consecutive years, earning it the status of a dividend aristocrat.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.48 | $0.64 | $0.64 | $0.56 | $0.50 | $0.43 | $0.40 | $0.38 | $0.35 | $0.35 | $0.31 | $0.29 |
Dividend yield | 4.14% | 5.60% | 3.37% | 1.57% | 1.57% | 0.77% | 0.76% | 0.66% | 0.94% | 0.53% | 0.54% | 0.48% |
Monthly Dividends
The table displays the monthly dividend distributions for DENTSPLY SIRONA Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| 2025 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.64 |
| 2024 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.64 |
| 2023 | $0.00 | $0.00 | $0.14 | $0.00 | $0.00 | $0.14 | $0.00 | $0.00 | $0.14 | $0.00 | $0.00 | $0.14 | $0.56 |
| 2022 | $0.00 | $0.00 | $0.13 | $0.00 | $0.00 | $0.13 | $0.00 | $0.00 | $0.13 | $0.00 | $0.00 | $0.13 | $0.50 |
| 2021 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.11 | $0.00 | $0.00 | $0.11 | $0.00 | $0.00 | $0.11 | $0.43 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the DENTSPLY SIRONA Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the DENTSPLY SIRONA Inc. was 84.28%, occurring on Nov 20, 2025. The portfolio has not yet recovered.
The current DENTSPLY SIRONA Inc. drawdown is 81.29%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -84.28% | May 11, 2021 | 1140 | Nov 20, 2025 | — | — | — |
| -52.84% | Jan 14, 2008 | 290 | Mar 9, 2009 | 1136 | Sep 11, 2013 | 1426 |
| -52.7% | Nov 29, 2017 | 581 | Mar 23, 2020 | 279 | Apr 30, 2021 | 860 |
| -44.82% | Jan 19, 1993 | 479 | Dec 8, 1994 | 537 | Jan 23, 1997 | 1016 |
| -41.17% | Mar 13, 1998 | 151 | Oct 15, 1998 | 452 | Aug 1, 2000 | 603 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of DENTSPLY SIRONA Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how DENTSPLY SIRONA Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for XRAY relative to other companies in the Medical Instruments & Supplies industry. Currently, XRAY has a P/S ratio of 0.6. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for XRAY in comparison with other companies in the Medical Instruments & Supplies industry. Currently, XRAY has a P/B value of 1.7. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |